An assessment of the impact of thimerosal on childhood neurodevelopmental disorders

Pediatric Rehabilitation

Volumn 6, Issue 2, 2003, Pages 97-102

  Geier, David A ^a   Geier, Mark R ^a  

^a Genetic Centers of America   (United States)

Author keywords

Autism; Mental retardation; Speech disorders; VAERS

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MERCURY; THIOMERSAL; VACCINE;

ARTICLE; AUTISM; CHILD; CHILDHOOD DISEASE; DEVELOPMENTAL DISORDER; DIPHTHERIA; DISEASE ASSOCIATION; FOOD AND DRUG ADMINISTRATION; HUMAN; MENTAL DEFICIENCY; NEUROTOXICITY; PERSONALITY DISORDER; PERTUSSIS; PREVALENCE; PRIORITY JOURNAL; SPEECH DISORDER; TETANUS; VACCINATION;

AUTISTIC DISORDER; CHILD; DEVELOPMENTAL DISABILITIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; ODDS RATIO; PERSONALITY DISORDERS; PRESERVATIVES, PHARMACEUTICAL; SPEECH DISORDERS; THIMEROSAL; UNITED STATES;

EID: 0142060003     PISSN: 13638491     EISSN: None     Source Type: Journal    
DOI: 10.1080/1363849031000139315     Document Type: Article

References (18)

1. GEIER, M. R. and GEIER, D. A.: Neurodevelopmental disorders following thimerosal-containing childhood vaccines. Experimental Biology and Medicine, in press.
2. GEIER, M. R. and GEIER, D. A.: Thimerosal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States. Journal of American Physicians and Surgeons, 8: 6-11, 2003.
3. rd annual report (Washington, DC: Office of Special Education Programs); A-14, 2001.
4. BALL, L. K., BALL, R. and PRATT, R. D.: An assessment of thimerosal use in childhood vaccines. Pediatrics, 107: 1147-1154, 2001.
5. NIU, M. T., RHODES, A., SALIVE, M. et al.: Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Events Reporting System (VAERS) and Vaccine Safety Datalink (VSD). Journal of Clinical Epidemiology, 51: 503-510, 1998.
6. CENTERS FOR DISEASE CONTROL AND PREVENTION: Live births by age of mother and race: United States, 1933-98. http://www.cdc.gov/nchs/data/natality/mage33tr.pdf; Visited 1 January 2003.
7. INSTITUTE OF MEDICINE (US): Immunization safety review: Thimerosal-containing vaccines and neurodevelopmental disorders (Washington, DC: National Academy Press), 2001.
8. DIEM, K. and LENTNER, C. (editors): Geigy, scientific tables (Ardsley, NY: Geigy Pharmaceuticals), 1974.
9. GEIER, M. R., TRIGG, M. E. and MERRIL, M. R.: Fate of bacteriophage in non-immune germ-free mice. Nature, 246: 221-222, 1973.
10. BURD, L., FISHER, W. and KERBESHIAN, J.: A prevalence study of pervasive developmental disorders in North Dakota. Journal of the American Academy of Childhood and Adolescent Psychiatry, 26: 700-703, 1987.
11. RITVO, E. R., FREEMAN, B. J., PINGREE, C. et al.: The UCLA-University of Utah epidemiologic survey of autism: prevalence. American Journal of Psychiatry, 146: 194-199, 1989.
12. YEARGIN-ALLSOPP, M., RICE, C., KARAPURKAR, T. et al.: Prevalence of autism in a US metropolitan area. Journal of the America Medicine Association, 289: 49-55, 2003.
13. BERNARD, S., ENAYATI, A., REDWOOD, L. et al.: Autism: a novel form of mercury poising. Medical Hypothesis, 56: 462-471, 2001.
14. MAGOS, L., BROWN, A. W., SPARROW, S. el al.: The comparative toxicology of ethyl- and methylmercury. Archives of Toxicology 57: 260-267, 1985.
15. CLARKSON, T. W.: The three faces of mercury. Environmental Health Perspectives, 110 (Suppl 1): 11-23, 2002.
16. CERNICHIARI, E., BREWER, R. G., MYERS, J. et al.: Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology, 16: 705-710, 1995.
17. CARTY, A. J. and MALONE, S. F.: The chemistry of mercury in biological systems. In: J. O. Nriagu (editor) The biogeochemistry of mercury in the environment (New York: Elsevier/North Holland), pp. 433-459, 1979.
18. PICHICHERO, M. E., CERNICHIARI, E., LOPREIATO, J. et al.: Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: a descriptive study. Lancet, 360: 1737-1741, 2002.